I've been gone a few days and am surprised to see so little action on what is really a great thread. As some investors, unfortunately large ones, who own this stock below $4 (I wish I were one) took large hits on other investments, they are now selling SNRS to shore up better short term positions. This is smart investing, and they still maintain significant investments in SNRS.
With no real good news on the horizon, especially if Skane is correct about NASDAQ, Sunrise may languish lower. I haven't seen any TA lately but my guess is that support above $5 is weak.
Even those who don't trade stocks, who sold out at $7 a few weeks ago, may buy at $5.75 or so, unless other opportunities seem brighter.
As the lack of news indicates, there's is nothing to discuss on a daily basis. The feedback coming from Sunrise always seems inacurate, and that's frustrating, but worse, it always kills a stock.
FDA approval, without NASDAQ listing (is this even possible?)may move the stock back to near $10 a share. This is not what any of us were looking for.
I'm hanging in and I wish you the best of luck with your imminent decisions. |
